107 related articles for article (PubMed ID: 2893137)
1. Growth without growth hormone: the "invisible" GH syndrome.
Bistritzer T; Chalew SA; Lovchik JC; Kowarski AA
Lancet; 1988 Feb; 1(8581):321-3. PubMed ID: 2893137
[TBL] [Abstract][Full Text] [Related]
2. Serum growth hormone levels measured by radioimmunoassay and radioreceptor assay: a useful diagnostic tool in children with growth disorders?
Ilondo MM; Vanderschueren-Lodeweyckx M; De Meyts P; Eggermont E
J Clin Endocrinol Metab; 1990 May; 70(5):1445-51. PubMed ID: 2186059
[TBL] [Abstract][Full Text] [Related]
3. Growth failure with plasma GH that is normal by RIA but low by radioreceptor assay: responsiveness to exogenous GH.
Bistritzer T; Chalew SA; Kowarski AA
Horm Res; 1995; 43(6):261-5. PubMed ID: 7607611
[TBL] [Abstract][Full Text] [Related]
4. Increased circulating radioreceptor-active growth hormone in insulin-dependent diabetics.
MacFarlane IA; Stafford SM; Wright AD
Clin Endocrinol (Oxf); 1986 Nov; 25(5):607-16. PubMed ID: 3621625
[TBL] [Abstract][Full Text] [Related]
5. Acute somatomedin response to growth hormone: radioreceptor assay versus radioimmunoassay.
Kemp SF; Rosenfeld RG; Liu F; Gaspich S; Hintz RL
J Clin Endocrinol Metab; 1981 Apr; 52(4):616-21. PubMed ID: 7204536
[TBL] [Abstract][Full Text] [Related]
6. Measuring growth hormone activity through receptor and binding protein assays.
Ilondo MM; Vanderschueren-Lodeweyckx M; De Meyts P
Horm Res; 1991; 36 Suppl 1():21-6. PubMed ID: 1806479
[TBL] [Abstract][Full Text] [Related]
7. Evidence for higher proportion of "little" growth hormone with increased radioreceptor activity in acromegalic plasma.
Gorden P; Lesniak MA; Eastman R; Hendricks CM; Roth J
J Clin Endocrinol Metab; 1976 Aug; 43(2):364-73. PubMed ID: 950368
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone assessment by radioreceptor and radioimmunoassay. Radioreceptor assay and radioimmunoassay comparisons.
LaFranchi S; Hanna CE; Jelen B
Am J Dis Child; 1984 Jan; 138(1):23-7. PubMed ID: 6537873
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone bioactivity in girls with Turner's syndrome: correlation with insulin-like growth factor I.
Foster CM; Borondy M; Markovs ME; Hopwood NJ; Kletter GB; Beitins IZ
Pediatr Res; 1994 Feb; 35(2):218-22. PubMed ID: 7513079
[TBL] [Abstract][Full Text] [Related]
10. Bioactivity of human growth hormone in serum: validation of an in vitro bioassay.
Foster CM; Borondy M; Padmanabhan V; Schwartz J; Kletter GB; Hopwood NJ; Beitins IZ
Endocrinology; 1993 May; 132(5):2073-82. PubMed ID: 8477657
[TBL] [Abstract][Full Text] [Related]
11. Hypersomatotropism in pregnant women, as measured by a human liver radioreceptor assay.
Daughaday WH; Trivedi B; Winn HN; Yan H
J Clin Endocrinol Metab; 1990 Jan; 70(1):215-21. PubMed ID: 2294132
[TBL] [Abstract][Full Text] [Related]
12. Growth-hormone-binding protein in patients with acromegaly.
Amit T; Ish-Shalom S; Glaser B; Youdim MB; Hochberg Z
Horm Res; 1992; 37(6):205-11. PubMed ID: 1292973
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone--dependent growth failure.
Frazer T; Gavin JR; Daughaday WH; Hillman RE; Weldon VV
J Pediatr; 1982 Jul; 101(1):12-5. PubMed ID: 7086612
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of insulin-like growth factor (IGF) and IGF-binding protein responses to a single dose of growth hormone.
Lee PD; Durham SK; Martinez V; Vasconez O; Powell DR; Guevara-Aguirre J
J Clin Endocrinol Metab; 1997 Jul; 82(7):2266-74. PubMed ID: 9215305
[TBL] [Abstract][Full Text] [Related]
15. Homologous IM-9 lymphocyte radioreceptor and receptor modulation assays for human serum growth hormone.
Gavin JR; Trivedi B; Daughaday WH
J Clin Endocrinol Metab; 1982 Jul; 55(1):133-9. PubMed ID: 6281300
[TBL] [Abstract][Full Text] [Related]
16. Correlative study of radioreceptor assay and radioimmunoassay of serum growth hormone in children: normal children and HGH-treated pituitary dwarfs.
Garnier PE; Job JC
Acta Endocrinol (Copenh); 1977 Sep; 86(1):50-9. PubMed ID: 578613
[TBL] [Abstract][Full Text] [Related]
17. Ovine placental lactogen is a potent somatogen in the growth hormone (GH)-deficient rat: comparison of somatogenic activity with bovine GH.
Singh K; Ambler GR; Breier BH; Klempt M; Gluckman PD
Endocrinology; 1992 May; 130(5):2758-66. PubMed ID: 1374015
[TBL] [Abstract][Full Text] [Related]
18. Quantitative differences between immunological and receptor binding activities of hGH in pituitary adenomas from patients with acromegaly.
Hizuka N; Takano K; Shizume K; Asakawa K; Miyakawa M
Endocrinol Jpn; 1984 Dec; 31(6):719-24. PubMed ID: 6099801
[TBL] [Abstract][Full Text] [Related]
19. Radioreceptor-inactive growth hormone associated with stimulated secretion in normal subjects.
Sneid DS; Jacobs LS; Weldon VV; Trivedi BL; Daughaday H
J Clin Endocrinol Metab; 1975 Sep; 41(3):471-4. PubMed ID: 169286
[TBL] [Abstract][Full Text] [Related]
20. Correlative study of radioreceptor assay and radioimmunoassay of serum growth hormone (GH): screening for bioinactive GH in short statures.
Igarashi N; Minami S; Kajiwara S; Sato T
Acta Paediatr Jpn; 1987 Apr; 29(2):269-76. PubMed ID: 3150911
[No Abstract] [Full Text] [Related]
[Next] [New Search]
